It isn’t easy to transform innovations into a sustainable commercial business, PTI has done it and continues to do so. In this discussion with Oliver Stauffer, their CEO, we discuss the importance of packaging which is the last defense in protecting life sciences products as they make their way to patients and consumers. We also talk about creating and sustaining a culture of innovation and the need for regulatory clarity, now more than ever, from FDA.
The Catalent Story
The story of Catalent is one for the ages, an epic tale of growth and the establishment of what we now know as the modern pharmaceutical contract development and manufacturing organization. John Chiminski served as the CEO for fourteen extraordinary years and tells...



